Sangamo Therapeutics, Inc.
HTT REPRESSORS AND USES THEREOF

Last updated:

Abstract:

Disclosed herein are HTT repressors and methods and compositions for use of these HTT repressors. Disclosed herein are methods and compositions for diagnosing, preventing and/or treating Huntington's Disease. In particular, provided herein are methods and compositions for modifying (e.g., modulating expression of) an HD HTT allele so as to prevent or treat Huntington Disease, including mHTT repressors (that repress mHTT transcripts and thus also repress mHTT protein expression).

Status:
Application
Type:

Utility

Filling date:

15 Jan 2020

Issue date:

3 Mar 2022